CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 28, 2025	Dec. 29, 2024
Current assets:
Cash and cash equivalents	$ 335,502	$ 272,869
Short-term investments	223,316	0
Accounts receivable, net	4,631	4,566
Notes receivable, net	2,412	4
Inventory	15,224	7,664
Prepaid expenses and other current assets	7,547	9,903
Total current assets	588,632	295,006
Property and equipment, net	174,585	167,947
Long-term investments	89,451	0
Customer relationship intangibles and other intangibles, net	32,827	36,394
Operating lease, right-of-use assets	11,774	13,479
Goodwill	12,217	12,217
Other assets, non-current	4,223	2,126
Total assets	913,709	527,169
Current liabilities:
Accounts payable	21,311	9,492
Accrued expenses	8,928	19,843
Accrued compensation	7,214	8,228
Short-term debt	10,151	9,452
Deferred revenue	7,689	3,650
Other liabilities	5,281	3,036
Total current liabilities	60,574	53,701
Long-term debt, net	518,348	169,820
Warrant liability	16,632	28,380
Operating lease liabilities, non-current	11,413	13,293
Deferred revenue, non-current	300	3,774
Deferred tax liability	9,325	8,784
Other liabilities, non-current	14	14
Total liabilities	616,606	277,766
Commitments and Contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.0001 par value; authorized shares of 1,000,000,000; issued and outstanding shares of 215,367,757 and 190,559,335 as of September 28, 2025 and December 29, 2024, respectively	22	19
Additional paid-in-capital	1,296,114	1,067,951
Treasury stock, at cost	(58,385)	0
Accumulated other comprehensive loss	(658)	(143)
Accumulated deficit	(942,837)	(821,086)
Total Enovix stockholders’ equity	294,256	246,741
Non-controlling interest	2,847	2,662
Total equity	297,103	249,403
Total liabilities and equity	$ 913,709	$ 527,169